Cargando…
Gonadotropin-releasing hormone analogue and recombinant human growth hormone treatment for idiopathic central precocious puberty in girls
PURPOSE: To investigate the effectiveness and safety of gonadotropin-releasing hormone analogue (GnRHa) in combination with recombinant human growth hormone (rhGH) in girls with central precocious puberty (CPP). METHODS: Clinical data of 80 girls diagnosed with idiopathic central precocious puberty...
Autores principales: | Shi, Yuzhen, Ma, Ziyi, Yang, Xi, Ying, Yanqin, Luo, Xiaoping, Hou, Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794601/ https://www.ncbi.nlm.nih.gov/pubmed/36589818 http://dx.doi.org/10.3389/fendo.2022.1085385 |
Ejemplares similares
-
Body image and depression in girls with idiopathic precocious puberty treated with gonadotropin-releasing hormone analogue
por: Choi, Min-Seon, et al.
Publicado: (2016) -
Influence of Gonadotropin Hormone Releasing Hormone Agonists on Interhemispheric Functional Connectivity in Girls With Idiopathic Central Precocious Puberty
por: Chen, Tao, et al.
Publicado: (2020) -
Final height outcome of boys with idiopathic central precocious puberty treated with gonadotropin-releasing hormone analogue
por: Ma, Hua-mei, et al.
Publicado: (2013) -
Increased final adult height by gonadotropin-releasing hormone agonist in girls with idiopathic central precocious puberty
por: Lee, Hae Sang, et al.
Publicado: (2018) -
Prevalence of idiopathic scoliosis in girls with central precocious puberty: effect of a gonadotropin-releasing hormone agonist
por: Chung, Lindsey Yoojin, et al.
Publicado: (2020)